10.05.2015 Views

F REIGN TRADE - 中国国际贸易促进委员会

F REIGN TRADE - 中国国际贸易促进委员会

F REIGN TRADE - 中国国际贸易促进委员会

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

NORTH AMERICA<br />

November 2011, told analysts “privatization<br />

is a choice for the company to<br />

continue to be on the healthy path”<br />

given the difficult U.S. capital markets<br />

and numerous short-seller attacks on<br />

the company. His proposal to buy out<br />

the company, with financing by a bank<br />

and a private-equity fund, dating back<br />

to October 2010, would protect shareholders’<br />

interests, he said.<br />

The trend of U.S.-listed Chinese<br />

companies going private will continue<br />

for at least a few years, until U.S. investors<br />

regain their confidence in Chinese<br />

firms and the capital markets recover,<br />

said Donald Yang, managing partner<br />

at Abax Global Capital, an asset manager<br />

in which Morgan Stanley owns<br />

a minority stake. Abax Global, which<br />

oversees $900 million in private-equity<br />

and hedge-fund assets in Hong Kong,<br />

has provided financing for a handful<br />

of companies going private, including<br />

Harbin Electric.<br />

A source of business<br />

Taking companies private has<br />

become a major source of new China<br />

business for Roth Capital. The Newport<br />

Beach, Calif., firm is one of a<br />

growing number of banks that have<br />

sharply scaled back their mainland operations.<br />

Roth Capital, which has raised<br />

more than $3.1 billion in financing<br />

since 2003 for China-based companies<br />

that went public in the U.S. through<br />

IPOs and reverse mergers, was hired<br />

last year as a financial advisor to independent<br />

committees in the going-private<br />

transactions of Yucheng Technologies<br />

Ltd. and Shengtai Pharmaceutical<br />

Inc.<br />

The board-appointed committees’<br />

role is to evaluate the fairness of<br />

buyout offers made by the chairmen<br />

of Yucheng Technologies, a Chinese<br />

provider of information-technology<br />

services, and Shengtai Pharmaceutical,<br />

a maker of pharmaceutical raw materials<br />

such as glucose.<br />

Some in the industry question<br />

whether companies seeking to retreat<br />

from public markets will want to deal<br />

with the same banks and law firms that<br />

brought them there.<br />

Companies may think, “Why are<br />

you going back to the guy who got you<br />

into this?” says Jim O’Neill, co-founder<br />

of Jin Niu Investment Management in<br />

Beijing, which raises capital for Chinese<br />

companies and has advised three<br />

firms in the past year on going private.<br />

Mr. O’Neill said he has spoken with<br />

companies going private that are reluctant<br />

to hire the same advisors who took<br />

them public.<br />

Roth Capital said it has no prior<br />

banking relationship with either company,<br />

but declined to comment further.<br />

Argyle, Texas-based Halter<br />

Financial is advising Si Chen, chief<br />

executive officer of New York Stock<br />

Exchange-listed American Lorain<br />

Corp., a snack-foods company, on a<br />

going-private proposal he has made<br />

to shareholders. Halter, a major player<br />

in helping Chinese companies list in<br />

the U.S. through reverse mergers, also<br />

advised American Lorain on its 2007<br />

reverse merger.<br />

Meanwhile, Loeb & Loeb said it<br />

has worked on nearly a dozen goingprivate<br />

transactions for companies<br />

including Harbin Electric, Fushi Copperweld<br />

and Yongye International Inc.<br />

The law firm has an existing relationship<br />

with some of these companies:<br />

It represented Yongye in its reversemerger<br />

transaction in 2008, and Harbin<br />

Electric and Fushi Copperweld in<br />

financing deals when they upgraded<br />

to the Nasdaq Stock Market from the<br />

OTC Bulletin Board in 2007.<br />

Mr. Nussbaum said the firm’s<br />

role in helping companies access the<br />

U.S. securities market years ago doesn’t<br />

compromise its ability to represent<br />

them now. In privatization transactions,<br />

“there’s a role for someone who<br />

knows the company well,” he said.<br />

67

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!